MannKind Corporation (MNKD)
| Market Cap | 1.13B |
| Revenue (ttm) | 74.51M |
| Net Income (ttm) | -86.11M |
| Shares Out | 249.30M |
| EPS (ttm) | -0.36 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,713,872 |
| Open | 4.61 |
| Previous Close | 4.56 |
| Day's Range | 4.46 - 4.61 |
| 52-Week Range | 1.78 - 6.25 |
| Beta | 1.95 |
| Analysts | Strong Buy |
| Price Target | 6.17 (+36.2%) |
| Est. Earnings Date | Nov 3, 2021 |
About MNKD
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. The company offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity used for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of Treprostinil (Tyva...
Financial Performance
In 2020, MNKD's revenue was $65.14 million, an increase of 3.34% compared to the previous year's $63.04 million. Losses were -$57.24 million, 10.3% more than in 2019.
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for MNKD stock is "Strong Buy." The 12-month stock price forecast is 6.17, which is an increase of 36.20% from the latest price.
News
Mannkind Corporation Participating at Upcoming Conferences
WESTLAKE VILLAGE, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients ...
United Therapeutics-MannKind's Formulated Tyvaso Shows Benefit In Pulmonary Hypertension Patients
United Therapeutics Corporation (NASDAQ: UTHR) has presented new clinical data from the BREEZE study evaluating Tyvaso DPI (treprostinil) in patients with pulmonary arterial hypertension (PAH). Related ...
MannKind Corporation to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
WESTLAKE VILLAGE, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients ...
The 6 Best Penny Stocks to Buy for September
Investing in penny stocks can be an intriguing numbers game. With many stocks to choose from, a handful are bound to be winners.
8 Best Penny Stocks To Buy Right Now According To Insiders
Insiders are buying these penny stocks right now. Should you?
Best Penny Stocks To Buy Right Now? 5 To Watch Before September
Looking for penny stocks to buy now? The post Best Penny Stocks To Buy Right Now?
MannKind (MNKD) Reports Q2 Loss, Tops Revenue Estimates
MannKind (MNKD) delivered earnings and revenue surprises of -25.00% and 31.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
MannKind: Q2 Earnings Insights
Shares of MannKind (NASDAQ:MNKD) moved higher by 3.1% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were unchanged 0.00% year over year to ($0.05), ...
MannKind Corporation Reports 2021 Second Quarter Financial Results
Conference Call to Begin Today at 5:00 PM ET
MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™ (aviptadil) Based On The T...
WESTLAKE VILLAGE, Calif., Aug. 4, 2021 /PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD) has partnered with NRx Pharmaceuticals (Nasdaq: NRXP) (NRx) to evaluate the feasibility of formulating a dry po...
NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respiratory Condit...
RADNOR, Pa., Aug. 4, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) announced today it has signed an agreement with MannKind Corporation to develop a dry powder formulation of ZYESAMI™ (a...
MannKind Corporation to Hold 2021 Second Quarter Financial Results Conference Call on August 11, 2021
WESTLAKE VILLAGE, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2021 second quarter financial results and its management will host a conference call to di...
3 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overa...
INDYCAR Driver Conor Daly To Share His Personal Diabetes Story And Race Go-Karts With Local Youth On Wednesday, Augus...
WESTLAKE VILLAGE, Calif., July 29, 2021 /PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD) will team up with NTT INDYCAR SERIES driver Conor Daly, who is living with Type 1 diabetes (T1D) for a one-of-...
MannKind (MNKD) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
MannKind (MNKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
7 Hot Penny Stocks Analysts Like To Watch In 2021
Current & Former Penny Stocks With High Marks From Analysts Right Now. The post 7 Hot Penny Stocks Analysts Like To Watch In 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...
Policy Change Allows Approval For Medicare Patients Living With Diabetes To Use Both Afrezza® And Continuous Glucose ...
WESTLAKE VILLAGE, Calif., June 28, 2021 /PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD) appreciates the recent efforts of the Centers for Medicare and Medicaid Services (CMS) in conjunction with the...
MannKind Presents Two Posters At American Diabetes Association's Virtual 81st Scientific Sessions, June 25-29
WESTLAKE VILLAGE, Calif., June 25, 2021 /PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD), which focuses on the development of innovative medicines for patients with endocrine and orphan lung diseases...
MannKind And United Therapeutics Achieve A Major Milestone In The Development Of Tyvaso DPI™ With New Drug Applicatio...
DANBURY, Conn., June 16, 2021 /PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD) and United Therapeutics Corporation (Nasdaq: UTHR) reached a major milestone today with the announcement that the U.S. F...
MannKind - United Therapeutics' Formulated Treprostinil Under FDA Review For Pulmonary Hypertension
MannKind Corporation (NASDAQ: MNKD) and United Therapeutics Corporation (NASDAQ: UTHR) have announced that the FDA has accepted for review the marketing application of Tyvaso DPI (inhaled treprostinil)....
MannKind and United Therapeutics Achieve a Major Milestone in the Development of Tyvaso DPI™ With New Drug Applicatio...
DANBURY, Conn., June 16, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) and United Therapeutics Corporation (Nasdaq: UTHR) reached a major milestone today with the announcement that the U....
MannKind and Thirona Bio Join Forces to Evaluate Potential Inhaled Therapy for Fibrotic Lung Diseases
MannKind will conduct formulation and preclinical studies of a new chemical entity owned by Thirona
MannKind Corporation at the Lytham Partners Summer 2021 Investor Conference
WESTLAKE VILLAGE, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients w...
MannKind Announces Data Presentation At 14th International Conference On Advanced Technologies & Treatments For Diabe...
WESTLAKE VILLAGE, Calif., June 3, 2021 /PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD), which focuses on the development of innovative medicines for patients with endocrine and orphan lung diseases,...
INDYCAR Driver Conor Daly To Share His Personal Diabetes Story And Race Go-karts With Local Youth On Tuesday, May 25th
WESTLAKE VILLAGE, Calif. and INDIANAPOLIS, May 20, 2021 /PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD) will team up with NTT INDYCAR SERIES driver Conor Daly, who is living with Type 1 diabetes (T1...